Alas, let's do some looking ahead. Eye on FDA has a nice preview of what's in store on the regulatory front for the upcoming year.
And worried about that 401K filled with company stock? Take heart in that Wall Street analysts are predicting that stock prices for most Big Pharma companies have nowhere to go but up. (Have we heard this before?)